Equity
€297,332 ▲ 3.4%
BETHANIE MEDICALE has made a profit without a break since 2016.
BETHANIE MEDICALE
Lifetime
14 annual accounts with figures on one time axispeak €80,239 (2022)
€12,710▼ 57.9%
lowest -€3,413 (2011)
€9,673▼ 57.5%
peak €297,332 (2024)
€297,332▲ 3.4%
€19,749▼ 38.9%
Board1 name since 2021
1 directorNTUNGILA NKAMA NGANA STANISLAS PEPIN
Documentsfilings and deeds
13-10-202574 days late
2024financial year
Turnover from €158,543 to €102,531Gross margin from €30,202 to €12,710Result from €22,750 to €9,673Debts from €32,341 to €19,749Cash from €19,053 to €1,558
Key points
from the 2024 annual accountsTurnover
€102,531 ▼ 35.3%
Turnover fell in 2024 from €158,543 to €102,531.
Payment terms
11 days to suppliers
BETHANIE MEDICALE pays its suppliers 3 days earlier than in 2023. Customers pay 1,113 days later.
Liquidity
16.06 was 9.89 in 2023
Short-term debts fell from €32,341 to €19,749.
Filings
14 annual accounts 99 days past the deadline
2025 accounts not filed: deadline was 31-07-2026.
Position in the sector
93.8%
Higher solvency than 93% of companies in human health. Sector median 55.3% · 1,240 companies.
Checked score
54
Fair
Financially stronger than 34% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%
A confirmed filing finding caps the score at 59.
Bankruptcy probability within 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%lowest value
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.4%▲ +0.1 percentage points vs 06-2025
08-2025: 0.4%● unchanged vs 07-2025
09-2025: 0.5%▲ +0.1 percentage points vs 08-2025
10-2025: 0.6%▲ +0.1 percentage points vs 09-2025
11-2025: 0.5%▼ -0.1 percentage points vs 10-2025
12-2025: 0.5%● unchanged vs 11-2025
01-2026: 0.5%● unchanged vs 12-2025
02-2026: 0.5%● unchanged vs 01-2026
03-2026: 0.6%▲ +0.1 percentage points vs 02-2026
04-2026: 0.6%● unchanged vs 03-2026
05-2026: 0.6%● unchanged vs 04-2026
06-2026: 0.5%▼ -0.1 percentage points vs 05-2026
07-2026: 0.5%● unchanged vs 06-2026
08-2026: 0.8%▲ +0.3 percentage points vs 07-2026
09-2026: 0.9%▲ +0.1 percentage points vs 08-2026
10-2026: 1.1%▲ +0.2 percentage points vs 09-2026highest value
11-2026: 1.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Capped at 59: a confirmed filing finding
Liquidity: current ratio 16.06, cash €1,558, halved
Figures for financial year 2024 (filed on 15-10-2025)
1 financial year not filed after the legal deadline; last filed accounts filed 74 days late; 3 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 23% on liquidity, 7% on profitability and 23% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2024.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 10,904 companies had the same profile as BETHANIE MEDICALE has now. Each dot stands for 28 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
The bankruptcy probability of BETHANIE MEDICALE itself is higher: 1.1% within 12 months. It rests on far more data about BETHANIE MEDICALE than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,904 companies, not a prediction for BETHANIE MEDICALE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €10,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity is ample, with a current ratio of 16.06 (9.89 in 2023), above the usual 1.5. Short-term debt is 6.2% and cash 0.5% of total assets. 6.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 99 days later.
NBB · 10 filingsPosition against the passed deadline
31-12-2025 year end31-07-2026 deadline07-11-2026 today
raises risk · 2024 accounts filed 74 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 13-10-2025, 74 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
74 days late
2023
68 days late
2022
217 days late
2021
85 days late
2020
192 days late
2019
192 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 138 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (1)
Recent changes
Incorporation
published on 27-08-2010 · Gazette deed
First establishment
Gustave Demeylaan 10, Auderghem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BETHANIE MEDICALE Sint-Gillis (bij-Brussel) | €317,081 | €12,710 | 93.8% | - |
| KHEMIS Anderlecht | €257,681 | €13,214 | 85.5% | - |
| DR. C. BROERS Lier | €255,113 | €12,492 | 75.0% | - |
| Dr. Heeren Jan Antwerp | €256,560 | €14,240 | 96.5% | - |
| DOKTER JOOST KLIJN Brasschaat | €365,629 | €10,437 | 49.4% | - |
| Dokter Leo VERMEERSCH Fysische Geneeskunde Leuven | €321,435 | €15,104 | 85.6% | - |
| MEDIKUTU Brussels | €344,385 | €20,745 | 85.5% | - |
These companies have the same main activity as BETHANIE MEDICALE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €255,000 and €366,000, founded between 2004 and 2013.
Official details
Source: KBO- Status
- Active since 18-08-2010Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.191.043.2251160 Auderghem, since 18-08-2010
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on BETHANIE MEDICALE
BETHANIE MEDICALE has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €297,332 and a net result of €9,673.
Equity has been growing by about 15% per year since 2018. Its solvency ranks better than 93% of 1,240 sector peers (NACE 86, financial year 2024).
The computed 12-month bankruptcy probability is 1.1% (low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BETHANIE MEDICALE
- What is the company number of BETHANIE MEDICALE?
- The company number of BETHANIE MEDICALE is 0828.548.363. The VAT number is the same number with BE in front: BE 0828.548.363.
- Where is BETHANIE MEDICALE based?
- The registered office is at Overwinningsstraat 49, 1060 Sint-Gillis (bij-Brussel).Company details
- What does BETHANIE MEDICALE do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of BETHANIE MEDICALE?
- BETHANIE MEDICALE is a private limited company (pre-2019) (BVBA).
- When was BETHANIE MEDICALE founded?
- BETHANIE MEDICALE was founded on 18-08-2010.
- Is BETHANIE MEDICALE still active?
- Yes, BETHANIE MEDICALE is an active enterprise in the KBO register.
- What is the turnover of BETHANIE MEDICALE?
- The turnover of BETHANIE MEDICALE was €102,531 in financial year 2024, according to the filed annual accounts.Financials
- Is BETHANIE MEDICALE profitable?
- In financial year 2024, BETHANIE MEDICALE made a profit of €9,673.
- Where can I find the annual accounts of BETHANIE MEDICALE?
- BETHANIE MEDICALE filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.